Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Last Wednesday, the National Institute for Health and Care Excellence (Nice) recommended the drug for use in NHS weight management services, saying it could help patients reduce their weight by more than 10%
KFF Health News is a national newsroom that produces journalism about health issues.
A successful weight management plan requires a comprehensive evaluation of all factors affecting weight and a personalized treatment plan that includes dietary strategy, physical activity, behavioral modifications, and other components tailored to the individual, she explains
In a Phase II study published in The New England Journal of Medicine, participants with obesity who received the highest dose of Retatritude (12 mg) experienced an average weight loss of 24.2% over 48 weeks
Magnesium deficiency is similarly significant and arguably more commonly overlooked
EPP is the primary approved clinical indication for Afamelanotide and has generated the most extensive translational research programme characterising MT-1s photoprotection mechanisms in human subjects
US$ 22.59
US$ 28.42
US$ 26.47
US$ 28.56
US$ 29.74
US$ 20.24
